Abstract Background Pediatric hematopoietic stem cell transplantation (HSCT) recipients are one of the high-risk groups concerning tuberculosis and screening for latent tuberculosis infection (LTBI) prior to HSCT is important and accurate diagnostic tests for predicting LTBI in these high-risk children are on demand. However, there are concerns for Interferon-gamma release assay(IGRA) being less sensitive in the children group for screening LTBI. This study was aimed to evaluate the predictive value of Quantiferon-TB Gold test (QFT-G) using the enzyme-linked immunosorbent spot assay (T-SPOT.TB) in immunocompromised Korean children. Methods In this prospective observational study, children under age 20 who were scheduled for allogeneic HSCT at Asan Medical Center Children`s Hospital were enrolled during March 2017 and May 2018. QFT-G test and T-SPOT.TB were done prior to HSCT. Concordance rates were calculated among each group. Electronic Medical Records was reviewed for clinical and demographic data of the enrolled patients. Results Among the 62 patients who were planned to receive allogenic HSCT during March 2017 and May 2018, 11 patients were excluded and a total of 51 patients were enrolled. Median age was 10 years and the underlying disease leading to HSCT was mostly aplastic anemia (31.4%). Others were acute myeloid leukemia (23.5%), acute lymphoblastic leukemia (15.7%), myelodysplastic syndrome (7.8%), and other benign disease (17.6%). About 52% of the patients were applied immunosuppressive drugs in the recent 3-month period prior to testing. 4 patients were considered LTBI based on screening test results. At 2 year follow up period, 1 patient was confirmed pulmonary TB. Overall concordance rate was 82.4% (42/51). The age-based concordance rate was 93.8% (14/15) for children younger than 5-years old and 77.8% (28/36) for 5 or above. Concordance rate between negative test results and not TB diagnosis was further checked; QFT-GIT 97.8% (44/45), T-SPOT. TB 97.9% (46/47), and TST 100% (10/10). Conclusion This study shows that the GFT-GIT well matched with the T-SPOT.TB for screening LTBI and children under age 5 showed to have higher concordance rates compared to the older age group. This could provide evidence to testing younger children with IGRA assays. Disclosures All Authors: No reported disclosures
Read full abstract